Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00093249 · ClinicalTrials.gov registry record · Phase 3
Study of Clevidipine Assessing Its Preoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-1)
A Phase 3 study, sponsored by The Medicines Company.
- Completed
- Registry status
- Phase 3
- Development phase
- 105
- Enrollment target
NCT00093249 is a Phase 3 study that has completed, run by The Medicines Company. The registered enrollment target is 105 participants.
The verdict
NCT00093249, a Phase 3 study, has completed, sponsored by The Medicines Company.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 105 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the efficacy of clevidipine injection versus placebo in treating preoperative hypertension.
Interventions
- DRUG placebo
- DRUG clevidipine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2004-01 |
| Est. Completion | 2004-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00093249
The ClinicalTrials.gov registry entry for NCT00093249 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Medicines Company, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00093249 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00093249 about?
NCT00093249 is a clinical study titled "Study of Clevidipine Assessing Its Preoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-1)". The purpose of this study is to determine the efficacy of clevidipine injection versus placebo in treating preoperative hypertension.
What is the current status of trial NCT00093249?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 105 participants. The study started on 2004-01. Estimated completion is 2004-11.
What interventions are being tested in trial NCT00093249?
The interventions under investigation include: placebo (DRUG), clevidipine (DRUG).
Who is sponsoring clinical trial NCT00093249?
This trial is sponsored by The Medicines Company, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.